Mechanisms of extracellular signal-regulated kinase (ERK) 1/2 phosphorylation following activation of relaxin family peptide receptor 3 (RXFP3) by human relaxin-3 (H3 relaxin).

被引:0
|
作者
van der Westhuizen, Emma T. [1 ]
Sexton, Patrick M. [1 ]
Summers, Roger J. [1 ]
机构
[1] Monash Univ, Dept Pharmacol, Monash, Vic 3800, Australia
来源
关键词
relaxin-3; G - protein coupled receptor; signal transduction;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:392 / 393
页数:2
相关论文
共 50 条
  • [41] Synthesis and pharmacological characterization of a europium-labelled single-chain antagonist for binding studies of the relaxin-3 receptor RXFP3
    Haugaard-Kedstroem, Linda M.
    Wong, Lilian L. L.
    Bathgate, Ross A. D.
    Rosengren, K. Johan
    AMINO ACIDS, 2015, 47 (06) : 1267 - 1271
  • [42] Synthesis and pharmacological characterization of a europium-labelled single-chain antagonist for binding studies of the relaxin-3 receptor RXFP3
    Linda M. Haugaard-Kedström
    Lilian L. L. Wong
    Ross A. D. Bathgate
    K. Johan Rosengren
    Amino Acids, 2015, 47 : 1267 - 1271
  • [43] Involvement of relaxin-family peptide-3 receptor (RXFP3) in the ventral dentate gyrus of the hippocampus in spatial and fear memory in rats
    Vafaei, Zohreh
    Khodagholi, Fariba
    Nategh, Mohsen
    Nikseresht, Sara
    Hashemirad, Seyed Reza
    Raise-Abdullahi, Payman
    Vafaei, Abbas Ali
    Motamedi, Fereshteh
    PEPTIDES, 2024, 178
  • [44] Development of a LC-MS/MS Quantification Assay for Human Relaxin H2 and Extraction of Human Relaxin H1 and Relaxin H3
    Fueloep, Annabelle
    Armbruster, Franz P.
    Groen, Hans J.
    Dschietzig, Thomas B.
    Diesner, Max
    CLINICAL LABORATORY, 2024, 70 (02) : 440 - 444
  • [45] Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer’s disease patients
    Jasinda H. Lee
    Shu Qing Koh
    Simone Guadagna
    Paul T. Francis
    Margaret M. Esiri
    Christopher P. Chen
    Peter T.-H. Wong
    Gavin S. Dawe
    Mitchell K. P. Lai
    Psychopharmacology, 2016, 233 : 591 - 598
  • [46] Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients
    Lee, Jasinda H.
    Koh, Shu Qing
    Guadagna, Simone
    Francis, Paul T.
    Esiri, Margaret M.
    Chen, Christopher P.
    Wong, Peter T. -H.
    Dawe, Gavin S.
    Lai, Mitchell K. P.
    PSYCHOPHARMACOLOGY, 2016, 233 (04) : 591 - 598
  • [47] Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications
    Ganella, Despina E.
    Ryan, Philip J.
    Bathgate, Ross A. D.
    Gundlach, Andrew L.
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (5-6): : 516 - 525
  • [48] Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice
    Zhang, Cary
    Chua, Berenice E.
    Yang, Annie
    Shabanpoor, Faze
    Hossain, Mohammad Akhter
    Wade, John D.
    Rosengren, K. Johan
    Smith, Craig M.
    Gundlach, Andrew L.
    BEHAVIOURAL BRAIN RESEARCH, 2015, 292 : 125 - 132
  • [49] The TRY-motif in the Relaxin Family Peptide Receptor 3 (RXFP3) functions as a Molecular Switch Between DNA Damage Response and Cell Cycle Control
    Leysen, Hanne
    van Gastel, Jaana
    Vangenechten, Laura
    Santos-Otte, Paula
    Verswyvel, Jasper
    van Turnhout, Jens
    Azmi, Abdelkrim
    Martin, Bronwen
    Maudsley, Stuart
    FASEB JOURNAL, 2021, 35
  • [50] RELAXIN enhances differentiation and matrix mineralization through Relaxin/insulin-like family peptide receptor 2 (Rxfp2) in MC3T3-E1 cells in vitro
    Duarte, Carolina
    Kobayashi, Yukiho
    Kawamoto, Tatsuo
    Moriyama, Keiji
    BONE, 2014, 65 : 92 - 101